Polsinelli Receives Multiple Honors at 2026 Turnaround Atlas Awards
Polsinelli is pleased to announce that the firm earned three dealmaking awards at the 2026 Turnaround Atlas Awards presented by Global M&A Network. In addition, co-head of Polsinelli’s Special Situations & Alternative Investments Practice Mark B. Joachim was named among Global M&A Network’s Top 50 Restructuring Lawyers.
Polsinelli was recognized in the following categories:
- Corporate Restructuring of the Year (Lower Mid-Markets) for its representation in the restructuring of Schwazze
- Healthcare Services Restructuring of the Year for its representation of Concordance Healthcare Solutions
- Special Situation M&A Deal of the Year for its representation of Astrana in connection with the Prospect Medical Chapter 11 reorganization and sale of multiple assets
The Turnaround Atlas Awards recognize outstanding value-creating transactions, restructurings and professionals in the global turnaround, insolvency and distressed investing sectors.
Polsinelli’s nationally recognized Bankruptcy & Restructuring Practice represents Chapter 11 debtors, distressed borrowers and buyers and sellers of distressed assets. The group also represents official committees, trustees, individual creditors such as equity security holders, vendors, landlords and bankruptcy litigants throughout the United States. The team also focuses on non-bankruptcy alternatives, including assignments for the benefit of creditors, out-of-court workouts, receiverships and state court liquidations. In collaboration with Polsinelli’s top-ranked Health Care Practice, the Bankruptcy & Restructuring Practice provides a special focus on distressed health care.
Polsinelli’s market-leading Health Care Mergers & Acquisitions Practice provides clients with complex transactional advice regarding mergers and acquisitions, investments, majority and minority recapitalizations and joint ventures and strategic alliances. Attorneys in the Health Care Mergers & Acquisitions Practice have advised on more than $40 billion in health care industry deals since 2018 with enterprise values covering the range of small-, mid- and large-cap. The group is especially active in advising on mergers and acquisitions of middle-market health care businesses, recognizing the importance of those middle-market deals in realizing the future of health care in America.